Team Heald
Medically Reviewed By:
Dr Sumeet Arora
TL;DR
Sleep apnea can disrupt oxygen levels and sleep quality, which may worsen insulin resistance and make blood sugar harder to control.
People with type 2 diabetes have a higher likelihood of undiagnosed obstructive sleep apnea, and the relationship appears to go both ways.
Treating sleep apnea may support better metabolic health, but results vary and it should be viewed as part of a broader care plan.
If you snore loudly, wake up gasping, or feel tired despite sleep, it is worth asking a clinician about sleep apnea screening.
For people trying to improve blood sugar and sleep at the same time, a structured program can make the connection easier to manage. Heald's approach can help users track sleep patterns, recognize possible apnea-related symptoms, and connect those patterns with glucose trends so they can discuss next steps with a clinician.
That kind of support is especially useful when the problem is not obvious. If fatigue, snoring, or overnight glucose swings keep showing up together, a data-driven plan can help turn scattered symptoms into a clearer care conversation.
What is the connection between sleep apnea and blood sugar?
Sleep apnea can affect blood sugar by fragmenting sleep and lowering oxygen levels overnight, both of which may increase stress hormones and insulin resistance. Over time, that can make glucose control harder, especially in people already at risk for prediabetes or type 2 diabetes.
Obstructive sleep apnea (OSA) is more than loud snoring. It causes repeated pauses in breathing during sleep, which can trigger brief awakenings and oxygen drops. Those changes can influence how the body handles glucose the next day.
Research and public health guidance consistently link poor sleep with worse metabolic health. The CDC notes that sleep health affects metabolism and that sleep apnea can raise the risk of chronic conditions, including type 2 diabetes. In practical terms, sleep disruption may make blood sugar more variable and harder to predict.
This does not mean sleep apnea alone causes diabetes in every case. But it can be an important, often missed factor when someone has elevated fasting glucose, A1C that is difficult to improve, or unexplained fatigue alongside snoring or daytime sleepiness.
CDC sleep guidance notes sleep health affects metabolism and that sleep apnea is associated with chronic disease risk, including type 2 diabetes. (cdc.gov)
A PubMed-indexed review reports a strong association between obstructive sleep apnea, insulin resistance, glucose intolerance, and type 2 diabetes risk, even beyond obesity alone. (pmc.ncbi.nlm.nih.gov)
Why can sleep apnea make blood sugar harder to control?
Sleep apnea may worsen blood sugar control because repeated breathing interruptions can raise sympathetic nervous system activity, increase inflammation, and disturb hormones that regulate appetite and glucose. The result is often more insulin resistance and less stable overnight metabolism.
When breathing stops and starts during sleep, the body can respond as if it is under stress. That stress response may increase cortisol and other counter-regulatory hormones, which can push glucose higher and reduce insulin sensitivity.
Sleep fragmentation also affects behavior. People with untreated sleep apnea may feel more tired, move less, crave higher-calorie foods, or struggle to follow meal and medication routines. Those indirect effects can matter just as much as the physiology.
For people with diabetes, this can create a cycle: poor sleep worsens glucose control, and unstable glucose can further disrupt sleep quality. Breaking that cycle often requires both sleep-focused and metabolic care.
A 2022 PubMed review found diabetes-related traits such as hyperglycemia and insulin resistance may also be linked with higher obstructive sleep apnea risk, suggesting a bidirectional relationship. (pubmed.ncbi.nlm.nih.gov)
A state-of-the-art review in PubMed notes that CPAP studies have shown mixed effects on glucose markers, which suggests adherence and individual factors matter. (pmc.ncbi.nlm.nih.gov)
Who is most likely to have both sleep apnea and high blood sugar?
People with obesity, type 2 diabetes, prediabetes, high blood pressure, or loud snoring are more likely to have sleep apnea and blood sugar problems together. Risk is also higher when there is daytime sleepiness, morning headaches, or waking up choking or gasping.
Sleep apnea and metabolic disease often overlap. Excess body weight is a major risk factor for obstructive sleep apnea, and it is also strongly tied to insulin resistance. That overlap makes it easy for one condition to hide the other.
People with type 2 diabetes may have sleep apnea without realizing it, especially if they assume fatigue is just part of diabetes. Likewise, someone being evaluated for sleep apnea may also benefit from screening for prediabetes or diabetes if they have other risk factors.
Public health sources emphasize that sleep apnea is common and frequently underrecognized. Because symptoms can be subtle during the day, many people only discover the problem after a partner notices snoring or breathing pauses.
A PubMed review reported that up to 83% of people with type 2 diabetes may have unrecognized obstructive sleep apnea in some clinical settings. (pmc.ncbi.nlm.nih.gov)
CDC heart-health guidance states sleep apnea affects oxygen delivery during sleep and is linked with multiple cardiovascular risks, which often cluster with metabolic disease. (cdc.gov)
Can treating sleep apnea improve blood sugar?
Treating sleep apnea may help improve blood sugar control for some people, especially when it reduces nighttime oxygen drops and sleep fragmentation. However, glucose benefits are not guaranteed, and outcomes depend on the cause of apnea, treatment adherence, weight, and overall diabetes care.
Continuous positive airway pressure, or CPAP, is the most common treatment for obstructive sleep apnea. By keeping the airway open, it can reduce breathing interruptions and improve sleep quality. That may support better daytime energy and more stable metabolic regulation.
Still, the research is mixed. Some studies show improvements in insulin sensitivity or glucose patterns, while others show smaller or inconsistent changes. That is one reason clinicians usually treat sleep apnea as part of a broader plan rather than a stand-alone fix for blood sugar.
Recent attention has also focused on weight-loss and metabolic therapies. In June 2024, the American Diabetes Association highlighted SURMOUNT-OSA findings showing tirzepatide improved sleep apnea severity and related metabolic issues in people with obesity and OSA. That does not replace standard care, but it reinforces the link between sleep and metabolism. (diabetes.org)
FAQs
Q: Can sleep apnea cause high blood sugar?
A: Sleep apnea may contribute to higher blood sugar by disrupting sleep and lowering oxygen levels, which can increase insulin resistance. It is not the only cause, but it can be an important factor in people with prediabetes or diabetes.
Q: Does CPAP lower blood sugar?
A: CPAP may help some people improve glucose control, but results vary. Benefits are more likely when treatment is used consistently and combined with weight management, nutrition, activity, and diabetes care.
Q: What are the signs that sleep apnea may be affecting my blood sugar?
A: Common clues include loud snoring, waking up gasping, morning headaches, daytime sleepiness, and blood sugar that stays hard to control despite following a treatment plan. A clinician can help decide whether sleep testing is appropriate.
Q: Should people with diabetes be screened for sleep apnea?
A: Many clinicians consider sleep apnea screening when a person has diabetes plus snoring, fatigue, obesity, or high blood pressure. Because the conditions often overlap, screening can uncover a missed contributor to poor metabolic control.

Sandeep Misra is the Co-Founder and Chief Growth Officer at Heald, where he leads growth strategy and partnerships for data-driven programs focused on diabetes reversal and metabolic health. He brings over two decades of experience across healthcare technology, population health, and enterprise partnerships, having held senior leadership roles at AWS, Rackspace, and NTT Data.
Comments
